Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Payables (2016 - 2025)

Prestige Consumer Healthcare has reported Payables over the past 15 years, most recently at $42.9 million for Q4 2025.

  • For Q4 2025, Payables rose 120.17% year-over-year to $42.9 million; the TTM value through Dec 2025 reached $42.9 million, up 120.17%, while the annual FY2025 figure was $18.9 million, 51.45% down from the prior year.
  • Payables for Q4 2025 was $42.9 million at Prestige Consumer Healthcare, up from $41.9 million in the prior quarter.
  • Over five years, Payables peaked at $64.3 million in Q4 2022 and troughed at $18.9 million in Q1 2025.
  • A 5-year average of $42.4 million and a median of $41.0 million in 2021 define the central range for Payables.
  • On a YoY basis, Payables climbed as much as 120.17% in 2025 and fell as far as 51.45% in 2025.
  • Year by year, Payables stood at $40.1 million in 2021, then skyrocketed by 60.22% to $64.3 million in 2022, then tumbled by 38.78% to $39.3 million in 2023, then crashed by 50.42% to $19.5 million in 2024, then surged by 120.17% to $42.9 million in 2025.
  • Business Quant data shows Payables for PBH at $42.9 million in Q4 2025, $41.9 million in Q3 2025, and $22.2 million in Q2 2025.